TE_26752
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | LTR17 |
|---|---|
| TE superfamily | ERV1 |
| TE class | LTR |
| Gene | LINC02335 |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 157.79 |
| Counts of samples | TCGA_tumor:699; TCGA_normal:3; GTEx:1 |
| TSS | chr13(+):55053967 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_26752.1 | LINC02335 | Chimeric | Non-coding | Non-coding | chr13(+):55053968,55054458,55062872,55063002,55106770,55106836,55160957,55160977 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
